Found 1291 clinical trials
Internet Intervention for Diabetes Distress.
This study is designed to investigate the potential effectiveness of an internet-delivered intervention for diabetes distress in patients with type 2 diabetes.
- 0 views
- 20 Jun, 2025
- 19 locations
SGLT2 Inhibition in Older Obese Adults With Pre-diabetes
Inhibitors of the sodium-glucose co-transporter (SGLT2) are FDA-approved for the treatment of type 2 diabetes (T2DM). Their mechanism of action involves lowering of blood glucose concentration secondary to increased glucose excretion of glucose by the kidney.
- 0 views
- 19 Feb, 2024
- 2 locations
Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)
Individuals with diabetes in the hospital often experience poor glycemic control, which places them at greater risk for infection, neurological and cardiac complications, mortality, longer lengths of stay, readmissions, and higher healthcare costs.
- 0 views
- 19 Feb, 2024
- 1 location
Incidence of Diabetes and Metabolic Disorders After TIPS in Cirrhotic Patients
Based on our retrospective data, TIPS induces in 30% of cirrhotic patients metabolic disorders associated with diabetes or pre-diabetes. The main objective is to measure the cumulative incidence of diabetes and pre-diabetes 6 months after TIPS insertion.
- 0 views
- 19 Feb, 2024
- 1 location
UPENN Case Test Trial 2 (Do Not Make Any Changes)
UPENN Case Test Trial 2 (Do Not Make Any Changes)
- 0 views
- 02 May, 2025
- 1 location
UPENN Case Test Trial 4 (Do Not Make Any Changes)
UPENN Case Test Trial 4 (Do Not Make Any Changes)
- 0 views
- 02 May, 2025
- 1 location
UPENN Case Test Trial 5 (Do Not Make Any Changes)
UPENN Case Test Trial 5 (Do Not Make Any Changes)
- 0 views
- 12 Jun, 2025
- 1 location
UPENN Case Test Trial 12 (Do Not Make Any Changes)
UPENN Case Test Trial 12 (Do Not Make Any Changes)
- 0 views
- 02 May, 2025
UPENN Case Test Trial 13 (Do Not Make Any Changes)
UPENN Case Test Trial 13 (Do Not Make Any Changes)
- 0 views
- 15 May, 2025
- 1 location
Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects
The objective of this early feasibility study is to evaluate the safety and performance of intravascular hepatic denervation using the Metavention Integrated Radio Frequency Denervation System (iRF System) to improve glycemic control in type 2 diabetes subjects.
- 0 views
- 19 Feb, 2024
- 5 locations